Retour
96
Fourchette du Jour
9,03 €
9,35 €
Fourchette 52 Semaines
6,19 €
13,16 €
Volume
663 515
Moyenne 50J / 200J
9,04 €
/
9,48 €
Clôture Précédente
9,42 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 6,5 | 0,3 |
| P/B | 3,5 | 2,9 |
| ROE % | 85,7 | 3,7 |
| Net Margin % | 78,2 | 3,8 |
| Rev Growth 5Y % | 38,8 | 10,0 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Hold
24,25 €
+165.0%
Low: 23,00 €
High: 26,00 €
P/E Prévisionnel
19,4
BPA Prévisionnel
0,49 €
Croissance BPA (est.)
+0,0%
CA Est.
140 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
3,42 €
3,00 € – 4,42 €
|
410 M | 5 |
| FY2029 |
3,04 €
2,67 € – 3,94 €
|
360 M | 2 |
| FY2028 |
2,51 €
1,60 € – 4,36 €
|
310 M | 7 |
Points Clés
Revenue grew 38,84% annually over 5 years — strong growth
ROE of 85,66% indicates high profitability
Net margin of 78,17% shows strong profitability
Debt/Equity of 0,41 — conservative balance sheet
Negative free cash flow of -2,43M
P/E of 6,45 — trading at a low valuation
Croissance
Revenue Growth (5Y)
38,84%
Revenue (1Y)350,91%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
85,66%
ROIC-1,46%
Net Margin78,17%
Op. Margin-3,98%
Sécurité
Debt / Equity
0,41
Current Ratio5,68
Interest Coverage-0,53
Valorisation
P/E Ratio
6,45
P/B Ratio3,47
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 350,91% | Revenue Growth (3Y) | 96,90% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 38,84% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 106,47M | Net Income (TTM) | 83,23M |
| ROE | 85,66% | ROA | 29,23% |
| Gross Margin | 84,52% | Operating Margin | -3,98% |
| Net Margin | 78,17% | Free Cash Flow (TTM) | -2,43M |
| ROIC | -1,46% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,41 | Current Ratio | 5,68 |
| Interest Coverage | -0,53 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 6,45 | P/B Ratio | 3,47 |
| P/S Ratio | 5,05 | PEG Ratio | -0,04 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 537,21M | Enterprise Value | 538,01M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 106,47M | 23,61M | 27,46M | 10,16M | 28,65M |
| Net Income | 83,23M | -105,51M | -46,05M | -26,77M | -8,56M |
| EPS (Diluted) | 1,35 | -2,28 | -1,30 | -0,78 | -2,11 |
| Gross Profit | 89,99M | 16,20M | 24,52M | 9,94M | 26,59M |
| Operating Income | -4,23M | -87,00M | -49,60M | -42,57M | 7,73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 284,73M | 178,13M | 172,33M | 115,34M | 132,94M |
| Total Liabilities | 130,07M | 138,46M | 110,46M | 40,22M | 5,82M |
| Shareholders' Equity | 154,66M | 39,67M | 61,86M | 75,12M | 127,12M |
| Total Debt | 63,21M | 60,30M | 43,77M | 18,78M | 1,61M |
| Cash & Equivalents | 62,41M | 33,79M | 43,05M | 65,47M | 112,35M |
| Current Assets | 223,01M | 86,03M | 86,94M | 92,83M | 115,06M |
| Current Liabilities | 39,28M | 34,07M | 73,72M | 12,02M | 4,23M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#3 of 670
Activité Récente
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026